2018 Has Been an Amazing Year at Cyntegrity!
2018 has been an amazing year at Cyntegrity! Thank you to everyone who made this possible!
Jan
2019
Nov
2018
Dr Johann Proeve awarded 2018 MCC Champion
MCC Congratulates the 2018 Class of MCC Champions: "MCC bestows this special honor to those individuals who made significant contributions in 2018 in advancing the MCC mission to improve the efficiency, quality and effectiveness of clinical trials."
Oct
2018
Data Integration – A Valid Concern or a Convenient Excuse?
Conference season has started! Our first stop was the Global RBM Summit 2018 in London. Our CSO Dr Johann Proeve was invited to join the conversation as a speaker on the topic “Pragmatic Centralized Monitoring – How to get there?”. Johann shares his observations with us.
Aug
2018
We Have Moved to a New Location!
Cyntegrity is growing! Our new office is 3 times bigger as before! We're excited to announce that our team has moved to a new, more spacious office in Frankfurt's science and technology center.
Jul
2018
DIA 2018 Global Annual Meeting: was this year’s theme the most dead-on yet?
The dramatic expansion of prescription drug deaths inspired this year's theme "driving insights to action". Insights that could be deployed through novel disruptive technologies such as Risk-based Quality Management (RBQM). Cyntegrity's Johann Proeve and Nimita Limaye were in Boston and share their observations with us.
Jun
2018
Medical Devices: Managing Risks Beyond Bullet Proof Clinical Evidence
The EU MDR is setting the stage for busy times ahead. The continuous need for clinical evidence, the increasing complexity of new medical devices, and the size and global nature of medical device trials introduce a greater potential for error. Learn how a risk-based approach enables MedTech manufacturers to better understand, manage and mitigate the growing uncertainties.
May
2018
Interview: “Oncology Trials are Different”
Many risks in clinical trials seem therapy specific. To illustrate this, Dr Johann Proeve shares real life use cases he experienced during his years as Head of Global Data Management at Bayer HealthCare.
May
2018
“OncoRACT” – The First Therapy Specific RACT for Clinical Trials
Many risks in clinical trials are therapy specific. Because of that, the currently available tools addressing those risks are now becoming therapy specific as well. The first therapy focused risk library Oncology RACT (OncoRACT) recently got available.
Apr
2018
Risk Based Budgeting: 5-Steps to Stay On-Budget
Yes you can stay on-budget! Read how Risk Based Budgeting (RBB) can help you keeping your clinical trial on-budget.
Mar
2018
Blockchain in Clinical Trials – The Ultimate Data Notary
Blockchain technology is the biggest achievement in cryptography of the past decade. Source Data Verification (SDV), which consumes about 20–30% of the clinical trial budget nowadays, will become redundant when blockchain technology disrupts the pharma industry.